Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Evommune, Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmed diagnosis of chronic inducible urticaria for at least 3 months.
Positive response following provocation using the TempTest or FricTest at Screening and Day 1.
You may not be if
History of diseases other than chronic inducible urticaria or chronic spontaneous urticaria with urticaria or angioedema symptoms, such as urticarial vasculitis, erythema multiforme, cutaneous mastocytosis (urticaria pigmentosa), and hereditary or acquired angioedema.
Concurrent use of certain medications, including antihistamines.
Any clinically significant disease, or other skin disease or skin markings (e.g., extensive scarring, tattoos), that might confound the evaluation of safety or efficacy.
Clareo Health | A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria
